IMMPRAME Trademark

Trademark Overview

On Wednesday, May 10, 2023, a trademark application was filed for IMMPRAME with the United States Patent and Trademark Office. The USPTO has given the IMMPRAME trademark a serial number of 97928918. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Monday, February 5, 2024. This trademark is owned by Immunocore Limited. The IMMPRAME trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers
immprame

General Information

Serial Number97928918
Word MarkIMMPRAME
Filing DateWednesday, May 10, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateMonday, February 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, Hodgkin's lymphoma, and head and neck cancers

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameImmunocore Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressAbingdon, Oxfordshire OX144RY
GB

Trademark Events

Event DateEvent Description
Monday, February 5, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, February 5, 2024LETTER OF SUSPENSION E-MAILED
Monday, February 5, 2024SUSPENSION LETTER WRITTEN
Monday, February 5, 2024ASSIGNED TO EXAMINER
Thursday, June 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, May 13, 2023NEW APPLICATION ENTERED

Related Keywords

immprame cancer preparations pharmaceutical reagents treatment bispecific biological myeloid leukemia cancers